This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Intellikine LLC, University of California. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 34 
1 out of 16,025 
Years Active: 2017
Title: Morris Feldman: Innovator in mTor Modulation
Introduction
Morris Feldman is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the modulation of protein kinases. His work has implications for therapeutic applications, showcasing the intersection of innovation and healthcare.
Latest Patents
Feldman's most recent patent is focused on "MTOR modulators and uses thereof." This invention provides methods and compositions for the selective modulation of certain protein kinases, especially mTor complexes. The methods and compositions are particularly useful in selectively inhibiting mTor for therapeutic applications.
Career Highlights
Throughout his career, Morris Feldman has worked with prestigious institutions, including the University of California and Intellikine LLC. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Feldman has collaborated with esteemed colleagues such as Kevan M. Shokat and David Fruman. These partnerships have enriched his work and expanded the impact of his inventions.
Conclusion
Morris Feldman's contributions to the field of biotechnology, particularly through his patent on mTor modulators, highlight his role as an innovator. His work continues to influence therapeutic applications and showcases the importance of collaboration in scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile